Patents by Inventor Ravinder N. Maini

Ravinder N. Maini has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Concomitant treatment of rheumatoid arthritis with anti-TNF-alpha antibodies and methotrexate
    Patent number: 8383120
    Abstract: Methods for treating and/or preventing a TNF-mediated disease in an individual are disclosed. Also disclosed is a composition comprising methotrexate and an anti-tumor necrosis factor antibody. TNF-mediated diseases include rheumatoid arthritis, Crohn's disease, and acute and chronic immune diseases associated with transplantation.
    Type: Grant
    Filed: January 13, 2012
    Date of Patent: February 26, 2013
    Assignee: The Mathilda and Terence Kennedy Institute of Rheumatology Trust
    Inventors: Marc Feldmann, Ravinder N. Maini
  • Concomitant treatment of rheumatoid arthritis with anti-TNF-? antibodies and methotrexate
    Patent number: 8298537
    Abstract: Methods for treating and/or preventing a TNF-mediated disease in an individual are disclosed. Also disclosed is a composition comprising methotrexate and an anti-tumor necrosis factor antibody. TNF-mediated diseases include rheumatoid arthritis, Crohn's disease, and acute and chronic immune diseases associated with transplantation.
    Type: Grant
    Filed: January 13, 2012
    Date of Patent: October 30, 2012
    Assignee: The Mathilda and Terence Kennedy Institute of Rheumatology Trust
    Inventors: Marc Feldmann, Ravinder N. Maini
  • TNF-alpha Antagonists and Methotrexate in the Treatment of TNF-Mediated Disease
    Publication number: 20120141475
    Abstract: Methods for treating and/or preventing a TNF-mediated disease in an individual are disclosed. Also disclosed is a composition comprising methotrexate and an anti-tumor necrosis factor antibody. TNF-mediated diseases include rheumatoid arthritis, Crohn's disease, and acute and chronic immune diseases associated with transplantation.
    Type: Application
    Filed: January 13, 2012
    Publication date: June 7, 2012
    Inventors: Marc Feldmann, Ravinder N. Maini
  • TNF-alpha Antagonists and Methotrexate in the Treatment of TNF-Mediated Disease
    Publication number: 20120141474
    Abstract: Methods for treating and/or preventing a TNF-mediated disease in an individual are disclosed. Also disclosed is a composition comprising methotrexate and an anti-tumor necrosis factor antibody. TNF-mediated diseases include rheumatoid arthritis, Crohn's disease, and acute and chronic immune diseases associated with transplantation.
    Type: Application
    Filed: January 13, 2012
    Publication date: June 7, 2012
    Inventors: Marc Feldmann, Ravinder N. Maini
  • TNFalpha antagonists and methotrexate in the treatment of TNF-mediated disease
    Publication number: 20110123543
    Abstract: Methods for treating and/or preventing a TNF-mediated disease in an individual are disclosed. Also disclosed is a composition comprising methotrexate and an anti-tumor necrosis factor antibody. TNF-mediated diseases include rheumatoid arthritis, Crohn's disease, and acute and chronic immune diseases associated with transplantation.
    Type: Application
    Filed: August 26, 2009
    Publication date: May 26, 2011
    Inventors: Marc Feldmann, Ravinder N. Maini
  • TNFalpha antagonists and methotrexate in the treatment of TNF-mediated disease
    Publication number: 20110014188
    Abstract: Methods for treating and/or preventing a TNF-mediated disease in an individual are disclosed. Also disclosed is a composition comprising methotrexate and an anti-tumor necrosis factor antibody. TNF-mediated diseases include rheumatoid arthritis, Crohn's disease, and acute and chronic immune diseases associated with transplantation.
    Type: Application
    Filed: August 26, 2009
    Publication date: January 20, 2011
    Inventors: Marc Feldmann, Ravinder N. Maini
  • Methods of treating rheumatoid arthritis with an anti-TNF-alpha antibodies and methotrexate
    Patent number: 7846442
    Abstract: Methods for treating and/or preventing a TNF-mediated disease in an individual are disclosed. Also disclosed is a composition comprising methotrexate and an anti-tumor necrosis factor antibody. TNF-mediated diseases include rheumatoid arthritis, Crohn's disease, and acute and chronic immune diseases associated with transplantation.
    Type: Grant
    Filed: September 12, 2005
    Date of Patent: December 7, 2010
    Assignee: The Mathilda and Terence Kennedy Institute of Rheumatology Trust
    Inventors: Marc Feldmann, Ravinder N. Maini
  • Methods of preventing or treating thrombosis with tumor necrosis factor antagonists
    Patent number: 7608262
    Abstract: A method of treating or preventing a cardiovascular and/or a cerebrovascular disorder in an individual is disclosed. Also disclosed is a method for treating and/or preventing a thrombotic disorder in an individual. Further disclosed is a method of decreasing plasma fibrinogen in an individual.
    Type: Grant
    Filed: February 16, 1996
    Date of Patent: October 27, 2009
    Assignee: The Kennedy Institute of Rheumatology
    Inventors: Michael J. Elliott, Ravinder N. Maini, Marc Feldmann
  • Methods of preventing or treating cardiovascular, cerebrovascular and thrombotic disorders with tumor necrosis factor antagonists
    Publication number: 20090263388
    Abstract: A method of treating or preventing a cardiovascular and/or a cerebrovascular disorder in an individual is disclosed. Also disclosed is a method for treating and/or preventing a thrombotic disorder in an individual. Further disclosed is a method of decreasing plasma fibrinogen in an individual.
    Type: Application
    Filed: June 4, 2009
    Publication date: October 22, 2009
    Inventors: Michael J. Elliott, Ravinder N. Maini, Marc Feldmann
  • Treatment of tumor necrosis factor-mediated diseases
    Publication number: 20040228863
    Abstract: A method of treating and/or preventing a TNF-mediated disease in an individual is disclosed. Also disclosed is a composition comprising a tumor necrosis factor antagonist and a CD4+ T cell inhibiting agent. TNF-mediated diseases include rheumatoid arthritis; Crohn's disease, and acute and chronic immune diseases associated with transplantation.
    Type: Application
    Filed: January 20, 2004
    Publication date: November 18, 2004
    Applicant: The Kennedy Institute of Rheumatology
    Inventors: Marc Feldmann, Ravinder N. Maini, Richard O. Williams
  • TNF&agr; antagonists and cyclosporin in therapy of rheumatoid arthritis
    Patent number: 6770279
    Abstract: A method for treating rheumatoid arthritis using a TNF&agr; antagonist in combination with cyclosporin or analog thereof is disclosed.
    Type: Grant
    Filed: June 8, 1998
    Date of Patent: August 3, 2004
    Assignee: The Kennedy Institute of Rheumatology
    Inventors: Marc Feldmann, Ravinder N. Maini, Richard O. Williams
  • Anti-TNF antibodies and methotrexate in the treatment of autoimmune disease
    Publication number: 20020136723
    Abstract: Methods for treating and/or preventing a TNF-mediated disease in an individual are disclosed. Also disclosed is a composition comprising methotrexate and an anti-tumor necrosis factor antibody. TNF-mediated diseases include rheumatoid arthritis, Crohn's disease, and acute and chronic immune diseases associated with transplantation.
    Type: Application
    Filed: August 3, 2001
    Publication date: September 26, 2002
    Applicant: The Kennedy Institute of Rheumatology
    Inventors: Marc Feldmann, Ravinder N. Maini
  • METHODS OF PREVENTING OR TREATING CARDIOVASCULAR, CEREBROVASCULAR AND THROMBOTIC DISORDERS WITH TUMOR NECROSIS FACTOR ANTAGONISTS
    Publication number: 20020081306
    Abstract: A method of treating or preventing a cardiovascular and/or a cerebrovascular disorder in an individual is disclosed. Also disclosed is a method for treating and/or preventing a thrombotic disorder in an individual. Further disclosed is a method of decreasing plasma fibrinogen in an individual.
    Type: Application
    Filed: February 16, 1996
    Publication date: June 27, 2002
    Inventors: MICHAEL J. ELLIOTT, RAVINDER N. MAINI, MARC FELDMANN
  • TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS
    Publication number: 20020068057
    Abstract: A method for treating autoimmune or inflammatory diseases, through the administration of a CD4+ T cell inhibiting agent, such as anti-CD4 antibody or cyclosporin A, in conjunction with or sequentially to a TNF antagonist, such as anti-TNF antibody or soluble TNF receptor, is disclosed. The method can be used to aid in therapy for humans and other mammals with a wide variety of autoimmune or inflammatory diseases.
    Type: Application
    Filed: May 10, 1996
    Publication date: June 6, 2002
    Inventors: MARC FELDMANN, RAVINDER N. MAINI, RICHARD O. WILLIAMS
  • TNFalpha antagonists and methotrexate in the treatment of TNF-mediated disease
    Publication number: 20020010180
    Abstract: Methods for treating and/or preventing a TNF-mediated disease in an individual are disclosed. Also disclosed is a composition comprising methotrexate and an anti-tumor necrosis factor antibody. TNF-mediated diseases include rheumatoid arthritis, Crohn's disease, and acute and chronic immune diseases associated with transplantation.
    Type: Application
    Filed: January 3, 2001
    Publication date: January 24, 2002
    Applicant: The Kennedy Institute of Rheumatology, England
    Inventors: Marc Feldmann, Ravinder N. Maini
  • Anti-TNF antibodies and methotrexate in the treatment of arthritis and crohn's disease
    Patent number: 6270766
    Abstract: Methods for treating and/or preventing a TNF-mediated disease in an individual are disclosed. Also disclosed is a composition comprising methotrexate and an anti-tumor necrosis factor antibody. TNF-mediated diseases include rheumatoid arthritis, Crohn's disease, and acute and chronic immune diseases associated with transplantation.
    Type: Grant
    Filed: August 1, 1996
    Date of Patent: August 7, 2001
    Assignee: The Kennedy Institute of Rheumatology
    Inventors: Marc Feldman, Ravinder N. Maini
  • Treatment of rheumatoid arthritis with anti-CD4 antibodies in conjunction with anti-TNF antibodies
    Patent number: 5741488
    Abstract: A method for treating autoimmune or inflammatory diseases, through the administration of anti-CD4 antibody in conjunction with or sequentially to anti-TNF antibody, is disclosed. The method can be used to aid in therapy for humans and other mammals with a wide variety of autoimmune or inflammatory diseases.
    Type: Grant
    Filed: May 3, 1995
    Date of Patent: April 21, 1998
    Assignee: The Kennedy Institute for Rheumatology
    Inventors: Marc Feldman, Ravinder N. Maini, Richard O. Williams